News

Meridian Capital Advises Bridger Technologies, Inc. on its Sale

09 August 2017

Seattle, Washington | August 9, 2017 – Meridian Capital LLC (“Meridian”) is pleased to announce the acquisition of its client Bridger Technologies, Inc. (“BTI”) by a publicly traded, NYSE listed, developer and manufacturer of products and solutions for the life science research and clinical diagnostic markets.  Meridian served as the exclusive financial advisor to BTI and its shareholders in this transaction.

BTI was founded in 2003 in Bozeman, Montana, by Fred G. Albert, Ph.D., and Brad W. Wright, Ph.D., P.E.  BTI is an early-stage research company that developed technology for accurate and rapid detection of bacteria, viruses and other targets, even in samples containing dust, urine, saliva or blood.  The company acquiring BTI plans to refine, produce, and commercialize this technology in a variety of critical market spaces.

“We are very proud of the scientific progress that we have made in developing BTI’s technology,” said Dr. Albert, speaking of his and Dr. Wright’s work at BTI.  “We think that BTI’s purchaser is the perfect successor to complete the technology’s development and use it to bring important new diagnostic products to market.”

Regarding the transaction, Dr. Wright stated: “We engaged Meridian in 2015 to explore options available to our shareholders and effectively communicate Bridger Tech’s market value to potential business partners.  Meridian was able to use its experience and industry knowledge to shepherd negotiations on behalf of BTI and successfully close this transaction, where the full value of BTI’s novel diagnostic technology will be realized.  Meridian’s hands-on, long term approach played a critical role in enabling BTI to navigate many complex issues.”  Added Dr. Albert, “All of us greatly appreciate the level of support and assistance that Meridian provided throughout the entire process.”

Patrick Ringland, Managing Director of Meridian, said, “Meridian has enjoyed a great partnership with BTI and its founders throughout our multi-year advisory relationship.  This transaction represents a tremendous outcome for the founders and other shareholders.  I am thrilled that our team could assist BTI in achieving its strategic and financial objectives.”